Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-000872-89Phase 4Completed
Phase 4, randomised, double-blind trial in postpartum infection and bacterial disease comparing Co-amoxiclav prophylaxis with Placebo / no prophylactic antibiotic (2 arms). Primary endpoint: Maternal infection within six weeks postpartum. Started Jun 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-000872-89.